Abstract: A door arrangement, for use on an aircraft, includes a door and an actuation arrangement. The arrangement is configured to move the door between an open position and a closed position. The actuation arrangement includes: a first member coupled to the door such that movement of the first member moves the door; a second member pivotally coupled to the first member and arranged to drive movement of the first member, wherein the second member is movable between a first position which corresponds to the door being in an open position and a second position which corresponds to the door being in a closed position; and an actuator arranged to rotate the second member between the first position and second positions. The door arrangement further comprises a fixed stop.

Abstract: A door arrangement, for use on an aircraft, includes a door and an actuation arrangement. The arrangement is configured to move the door between an open position and a closed position. The actuation arrangement includes: a first member coupled to the door such that movement of the first member moves the door; a second member pivotally coupled to the first member and arranged to drive movement of the first member, wherein the second member is movable between a first position which corresponds to the door being in an open position and a second position which corresponds to the door being in a closed position; and an actuator arranged to rotate the second member between the first position and second positions. The door arrangement further comprises a fixed stop.

Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Abstract: A cold junction compensation system for a temperature measurement device having a processing circuit is disclosed. The cold junction compensation system includes a cold junction temperature sensor arranged in signal communication with the processing circuit, a thermal coupler in thermal communication with the cold junction temperature sensor, and first and second contacts each in thermal communication with the thermal coupler and in electrical isolation with each other, each contact arranged for signal communication with the processing circuit and arranged for signal communication with a hot junction temperature sensor.